Literature DB >> 18295328

An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection.

Seong Loong Lo1, Shu Wang.   

Abstract

Peptides as functional biomaterials offer the possibility of incorporating various biological activities required for different biomedical applications. Here, we take advantage of this property of peptide materials and design a DNA delivery vector equipped with multiple functions critical to efficient gene transfection. The Tat peptide, a cationic cell-penetrating peptide, is known to enhance the cellular uptake of a large variety of molecules such as drugs and proteins. However, the application of the Tat peptide in DNA delivery is limited by the inability to release DNA in endosomes and the instability of peptide/DNA complexes. We incorporate in the Tat sequence histidine and cysteine residues that are able to promote endosomal escape of DNA and protect DNA in the extracellular environment. We observe up to 7000-fold improvement in gene transfection efficiency by a modified Tat peptide covalently fused with 10 histidine residues (Tat-10H) over the original Tat peptide. After incorporating two cysteine residues into the Tat-10H design, the resulting bis(cysteinyl) histidine-rich peptide is more effective than the Tat-10H peptide, because interpeptide disulfide bonds form by air oxidation upon binding to DNA, leading to enhanced stability of peptide/DNA complexes. These findings demonstrate the feasibility of using multi-functional peptide materials to extend the applications of the Tat vector to efficient gene delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295328     DOI: 10.1016/j.biomaterials.2008.01.031

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  64 in total

1.  Bioreducible polymers for gene delivery.

Authors:  Tae-Il Kim; Sung Wan Kim
Journal:  React Funct Polym       Date:  2011-03-01       Impact factor: 3.975

2.  Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination.

Authors:  Tien-Yi Lee; Yoon Shin Park; George A Garcia; Roger K Sunahara; James H Woods; Victor C Yang
Journal:  Mol Pharm       Date:  2012-03-28       Impact factor: 4.939

Review 3.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

Review 4.  Applying horizontal gene transfer phenomena to enhance non-viral gene therapy.

Authors:  Jacob J Elmer; Matthew D Christensen; Kaushal Rege
Journal:  J Control Release       Date:  2013-08-30       Impact factor: 9.776

Review 5.  Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.

Authors:  Ayman El-Sayed; Shiroh Futaki; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-01-06       Impact factor: 4.009

6.  Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors.

Authors:  Jiangbing Zhou; Toral R Patel; Michael Fu; James P Bertram; W Mark Saltzman
Journal:  Biomaterials       Date:  2011-10-19       Impact factor: 12.479

7.  Glycosylated cell-penetrating peptides and their conjugates to a proapoptotic peptide: preparation by click chemistry and cell viability studies.

Authors:  Laurence Dutot; Pascaline Lécorché; Fabienne Burlina; Rodrigue Marquant; Vanessa Point; Sandrine Sagan; Gérard Chassaing; Jean-Maurice Mallet; Solange Lavielle
Journal:  J Chem Biol       Date:  2009-11-10

Review 8.  Methods for Intracellular Delivery of Quantum Dots.

Authors:  Sueden O Souza; Rafael B Lira; Cássia R A Cunha; Beate S Santos; Adriana Fontes; Goreti Pereira
Journal:  Top Curr Chem (Cham)       Date:  2021-01-05

9.  Application of a proapoptotic peptide to intratumorally spreading cancer therapy.

Authors:  Renwei Chen; Gary B Braun; Xiuquan Luo; Kazuki N Sugahara; Tambet Teesalu; Erkki Ruoslahti
Journal:  Cancer Res       Date:  2012-12-17       Impact factor: 12.701

Review 10.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.